Literature DB >> 16002462

The role of protein kinase C isoforms in modulating injury and repair of the intestinal barrier.

A Farhadi1, A Keshavarzian, Z Ranjbaran, J Z Fields, A Banan.   

Abstract

Gastrointestinal cells express a diverse group of protein kinase C (PKC) isoforms that play critical roles in a number of cell functions, including intracellular signaling and barrier integrity. PKC isoforms expressed by gastrointestinal epithelial cells consist of three major PKC subfamilies: conventional isoforms (alpha, beta1, beta2, and gamma), novel isoforms (delta, epsilon, theta, eta, and mu), and atypical isoforms (lambda, tau, and zeta). This review highlights recent discoveries, including our own, that some PKC isoforms in gastrointestinal epithelia monolayer cell culture are involved in injury to, whereas others are involved in protection of, intestinal barrier integrity. For example, certain PKC isoforms aggravate oxidative damage, whereas others protect against it. These findings suggest that the development of agents that selectively activate or inhibit specific PKC isoforms may lead to new therapeutic modalities for important gastrointestinal disorders such as cancer and inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002462     DOI: 10.1124/jpet.105.085449

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  32 in total

1.  FTY720-induced human pulmonary endothelial barrier enhancement is mediated by c-Abl.

Authors:  L Wang; E T Chiang; J T Simmons; J G N Garcia; S M Dudek
Journal:  Eur Respir J       Date:  2010-11-11       Impact factor: 16.671

2.  Oxidative stress-induced disruption of epithelial and endothelial tight junctions.

Authors:  Radhakrishna Rao
Journal:  Front Biosci       Date:  2008-05-01

3.  Role of AMP-18 in oral mucositis.

Authors:  Peili Chen; Mark Lingen; Stephen T Sonis; Margaret M Walsh-Reitz; F Gary Toback
Journal:  Oral Oncol       Date:  2011-07-06       Impact factor: 5.337

4.  Systematic analysis of bacterial effector-postsynaptic density 95/disc large/zonula occludens-1 (PDZ) domain interactions demonstrates Shigella OspE protein promotes protein kinase C activation via PDLIM proteins.

Authors:  Chae-ryun Yi; John E Allen; Brian Russo; Soo Young Lee; Jason E Heindl; Leigh A Baxt; Bobby Brooke Herrera; Emily Kahoud; Gavin MacBeath; Marcia B Goldberg
Journal:  J Biol Chem       Date:  2014-09-08       Impact factor: 5.157

Review 5.  Enteric glial cells and their role in the intestinal epithelial barrier.

Authors:  Yan-Bo Yu; Yan-Qing Li
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

6.  Salmonella enteritidis Effector AvrA Stabilizes Intestinal Tight Junctions via the JNK Pathway.

Authors:  Zhijie Lin; Yong-Guo Zhang; Yinglin Xia; Xiulong Xu; Xinan Jiao; Jun Sun
Journal:  J Biol Chem       Date:  2016-11-15       Impact factor: 5.157

7.  PKCdelta mediates thrombin-augmented fibroblast-mediated collagen gel contraction.

Authors:  Qiuhong Fang; Lijun Mao; Tetsu Kobayashi; Xingqi Wang; Todd A Wyatt; Huijung Kim; Xiangde Liu; Stephen I Rennard
Journal:  Biochem Biophys Res Commun       Date:  2008-03-13       Impact factor: 3.575

8.  Probiotics ameliorate the hydrogen peroxide-induced epithelial barrier disruption by a PKC- and MAP kinase-dependent mechanism.

Authors:  A Seth; Fang Yan; D Brent Polk; R K Rao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-02-21       Impact factor: 4.052

9.  Restoration of Na+/H+ exchanger NHE3-containing macrocomplexes ameliorates diabetes-associated fluid loss.

Authors:  Peijian He; Luqing Zhao; Lixin Zhu; Edward J Weinman; Roberto De Giorgio; Michael Koval; Shanthi Srinivasan; C Chris Yun
Journal:  J Clin Invest       Date:  2015-08-10       Impact factor: 14.808

10.  Phosphorylation of alpha6-tubulin by protein kinase Calpha activates motility of human breast cells.

Authors:  Thushara P Abeyweera; Xiangyu Chen; Susan A Rotenberg
Journal:  J Biol Chem       Date:  2009-04-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.